Impact of a Lung Cancer Screening Counseling and Shared Decision‐Making Visit

[1]  M. Kegler,et al.  Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening , 2015, Cancer.

[2]  R. Wiener,et al.  Pulmonologists' Reported Use of Guidelines and Shared Decision-making in Evaluation of Pulmonary Nodules: A Qualitative Study. , 2015, Chest.

[3]  R. Wiener,et al.  Primary Care Providers and a System Problem: A Qualitative Study of Clinicians Caring for Patients With Incidental Pulmonary Nodules. , 2015, Chest.

[4]  M. Kelley,et al.  A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer. , 2015, Annals of the American Thoracic Society.

[5]  Elizabeth H. Payne,et al.  Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. , 2015, American journal of respiratory and critical care medicine.

[6]  M. Oudkerk,et al.  Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  J. Jett,et al.  Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. , 2015, Chest.

[8]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[9]  Glyn Elwyn,et al.  Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids , 2013, BMC Medical Informatics and Decision Making.

[10]  B. Kramer,et al.  The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung cancer histology , 2013, Cancer.

[11]  K. Dunnigan.  Tests of marginal homogeneity and special cases , 2013, Pharmaceutical statistics.

[12]  D. Naidich,et al.  Screening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[13]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[14]  G. Elwyn,et al.  Personalised risk communication for informed decision making about taking screening tests. , 2013, The Cochrane database of systematic reviews.

[15]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[16]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[17]  Lyndal Trevena,et al.  A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial , 2010, BMJ : British Medical Journal.

[18]  Carmen L. Lewis,et al.  Decision-Making Processes for Breast, Colorectal, and Prostate Cancer Screening: The DECISIONS Survey , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  William Mantovani,et al.  Self-Selection Effects in Smokers Attending Lung Cancer Screening: A 9.5-Year Population-Based Cohort Study in Varese, Italy , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  G. Silvestri,et al.  Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts , 2007, Thorax.